The present study was undertaken to deterumine whether there are any factors that may contribute to the occurrence of depression in hypertensive patients, whether Rauwolfia drugs actually do enhance the production of such reactions, and whether it is possible to predict which patients may be especially susceptible to a depressive reaction. More important than the average duration of treatment, however, is the great variation encountered. One patient became depressed in less than 1 month on a dose of 0.5 mg. a day. Another individual took 2.0 mg. daily for 20 months during the period studied without becoming depressed, only to become depressed 6 months later while taking the same dose. Although it appears that most depressive reactions will be manifest within the first 6 months of treatment, no patient taking Rauwolfia should ever be considered safe from the risk of depression, no matter how long lie may have tolerated the drug. The physician, the patient, and the patient's family should continue to be constantly alert for signs of depression in any person receiving Rauwolfia.
Symptomatology. The gross clinical features of the depressions that occurred in patients taking Rauwolfia were not particularly distinctive. Sometimes symptoms cleared up while patients continued to take substantial doses of the same Rauwolfia preparatioln. Most of the mild and some of the moderately severe depressions cleared promptly, after treatment with Rauwolfia was discolltinued. Many of the moderately severe depressionis, however, required additional medical therapy as well as some form of psychotherapy. The depressions cleared gradually in most cases, so that it was not possible to determine the average length of time that a depressive reaction lasted following cessation of the use of Rauwolfia.
Of the 8 patients with severe depression, some displayed chiefly agitation while others were retarded; 1 person made homicidal threats and there were 2 attempts at suicide, 1 of which was successfully carried out. Five of these 8 patients required electroconvulsive therapy to treat the depression adequately.
Nightmares were mentioned by many patients, and these were usually unpleasant, although 1 patient even enjoyed her exciting dreams. Many patients who otherwise tolerated the drug well had nightmares, and these seemed to have no relationship to depressive reactions.
COMMENT 1t was not surprising that mental depressionIs were found more frequently among patients treated with preparations of Rauwolfia serpentina than among those who did not receive this drug. However, it was disconcerting to find that depressive reactions were 
